No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
CollPlant's Collink.3D BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies
When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Breakeven?
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $14 Price Target
CollPlant Biotechnologies Analyst Ratings
Earnings Call Summary | Collplant(CLGN.US) Q4 2024 Earnings Conference
CollPlant's Earnings Call: Mixed Outlook Amid Innovations